-
Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk Management
Read more »: Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk ManagementThe FDA guidance on quality risk management released in May (2023) offers principles and examples applicable to various pharmaceutical quality aspects. The principles of quality risk management in this guidance can be extended to clinical trial vendor risk management, covering different stages of a clinical trial. When applied to clinical trial vendor risk management, the…
-
Vendor Level vs Study Level Vendor Risk Assessment: A Robust Approach
Read more »: Vendor Level vs Study Level Vendor Risk Assessment: A Robust ApproachClinical trial vendor management requires a strategic approach, proactive thinking, and a deep understanding of vendor risk assessment at both the vendor and study levels. Two approaches to vendor risk assessment — vendor level and study level — serve to manage different types of risk. The assessments are complementary and critical to clinical trial delivery.…
-
Welcome to Mayet: Spearheading change in Clinical Research Vendor Management
Read more »: Welcome to Mayet: Spearheading change in Clinical Research Vendor ManagementWe are excited to introduce Mayet, an innovative all-in-one solution in the world of clinical research outsourcing. Clinical research is a vital process that opens new avenues for treatment. However, it is fraught with complexities and challenges, particularly in the realm of vendor management. Fragmented systems, inefficient processes, lack of visibility, and increased risk are…